TY - JOUR
T1 - Efficacy of early controlled motion of the ankle compared with no motion after non-operative treatment of an acute Achilles tendon rupture
T2 - study protocol for a randomized controlled trial
AU - Barfod, Kristoffer Weisskirchner
AU - Hansen, Maria Swennergren
AU - Hølmich, Per
AU - Troelsen, Anders
AU - Kristensen, Morten Tange
PY - 2016/11/29
Y1 - 2016/11/29
N2 - Background: Early controlled ankle motion is widely used in the non-operative treatment of acute Achilles tendon rupture, though its safety and efficacy have never been investigated in a randomized setup. The objectives of this study are to investigate if early controlled motion of the ankle affects functional and patient-reported outcomes. Methods/design: The study is performed as a blinded, randomized, controlled trial with patients allocated in a 1:1 ratio to one of two parallel groups. Patients aged from 18 to 70years are eligible for inclusion. The intervention group performs early controlled motion of the ankle in weeks 3-8 after rupture. The control group is immobilized. In total, 130 patients will be included from one big orthopedic center over a period of 2 1/2years. The primary outcome is the patient-reported Achilles tendon Total Rupture Score evaluated at 12months post-injury. Secondary outcome measures are the heel-rise work test, Achilles tendon elongation, and the rate of re-rupture. The primary analysis will be conducted as intention-to-treat analyses. Discussion: This trial is the first to investigate the safety and efficacy of early controlled motion in the treatment of acute Achilles tendon rupture in a randomized setup. The study uses the patient-reported outcome measure, the Achilles tendon Total Rupture Score, as the primary endpoint, as it is believed to be the best surrogate measure for the tendon's actual capability to function in everyday life. Trial registration: ClinicalTrials.gov: NCT02015364. Registered on 13 December 2013.
AB - Background: Early controlled ankle motion is widely used in the non-operative treatment of acute Achilles tendon rupture, though its safety and efficacy have never been investigated in a randomized setup. The objectives of this study are to investigate if early controlled motion of the ankle affects functional and patient-reported outcomes. Methods/design: The study is performed as a blinded, randomized, controlled trial with patients allocated in a 1:1 ratio to one of two parallel groups. Patients aged from 18 to 70years are eligible for inclusion. The intervention group performs early controlled motion of the ankle in weeks 3-8 after rupture. The control group is immobilized. In total, 130 patients will be included from one big orthopedic center over a period of 2 1/2years. The primary outcome is the patient-reported Achilles tendon Total Rupture Score evaluated at 12months post-injury. Secondary outcome measures are the heel-rise work test, Achilles tendon elongation, and the rate of re-rupture. The primary analysis will be conducted as intention-to-treat analyses. Discussion: This trial is the first to investigate the safety and efficacy of early controlled motion in the treatment of acute Achilles tendon rupture in a randomized setup. The study uses the patient-reported outcome measure, the Achilles tendon Total Rupture Score, as the primary endpoint, as it is believed to be the best surrogate measure for the tendon's actual capability to function in everyday life. Trial registration: ClinicalTrials.gov: NCT02015364. Registered on 13 December 2013.
KW - Journal Article
U2 - 10.1186/s13063-016-1697-2
DO - 10.1186/s13063-016-1697-2
M3 - Journal article
C2 - 27894329
SN - 1745-6215
VL - 17
SP - 1
EP - 10
JO - Trials
JF - Trials
IS - 1
M1 - 564
ER -